BFR Training for ACL Recovery
Trial Summary
What is the purpose of this trial?
This is a crossover phase 4 study to evaluate the impact of blood flow restriction on immunometabolism and gene expression in immune cells in individuals undergoing rehabilitation from anterior cruciate ligament reconstruction.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, you cannot participate if you are using anticoagulant medications or have been treated with another investigational drug within one month of the study start.
What data supports the idea that BFR Training for ACL Recovery is an effective treatment?
The available research shows that BFR Training is effective for ACL recovery by helping to reduce muscle loss and improve knee strength. One study found that BFR Training helps increase quadriceps strength and size after ACL surgery. Another study highlights its benefits in reducing muscle weakness in adolescents after ACL reconstruction. Overall, BFR Training is shown to decrease muscle atrophy, which is a common issue after ACL surgery.12345
What safety data exists for BFR training?
Numerous studies over the past 25 years have demonstrated the relative safety and efficacy of blood flow restriction (BFR) training. It is used in various settings, including rehabilitation after anterior cruciate ligament reconstruction, and is considered beneficial for those who cannot tolerate high-load exercises due to its lower stress on tissues and joints.24678
Eligibility Criteria
This trial is for individuals aged 18-60 who are in good health and currently rehabilitating from anterior cruciate ligament reconstruction. Participants must be willing to follow the study procedures and have no recent smoking history, febrile illness, vascular issues in legs, or serious medical conditions like diabetes or rheumatoid arthritis.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo two training sessions with blood flow restriction (BFR) and control interventions using AirBands
Follow-up
Participants are monitored for immunometabolic responses and gene expression changes after each training session
Treatment Details
Interventions
- AirBand (Behavioural Intervention)